Plk1 promotes nuclear translocation of human Cdc25C during prophase

No abstract is available for this paper.

• Publication year

  2002

• Venue

  EMBO Reports

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/embo-reports/kvf069PMID 11897663PMCID PMC1084057
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein Phosphatase

  2001cited by this paper
• Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase

  2001influential reference
• Cell division: Mitotic kinases as regulators of cell division and its checkpoints

  2001influential reference
• Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding

  2001cited by this paper
• Combinatorial Control of Cyclin B1 Nuclear Trafficking through Phosphorylation at Multiple Sites*

  2001cited by this paper
• Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

  2000cited by this paper
• A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.

  1999cited by this paper
• Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal.

  1999cited by this paper
• Four-dimensional control of the cell cycle

  1999cited by this paper
• All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners.

  1999cited by this paper
• Maintenance of G2 arrest in the Xenopus oocyte: a role for 14‐3‐3‐mediated inhibition of Cdc25 nuclear import

  1999influential reference
• DNA Damage and Replication Checkpoints in Fission Yeast Require Nuclear Exclusion of the Cdc25 Phosphatase via 14-3-3 Binding

  1999cited by this paper
• Mitotic Effects of a Constitutively Active Mutant of the Xenopus Polo-Like Kinase Plx1

  1999cited by this paper
• Cytoplasmic Localization of Human cdc25C during Interphase Requires an Intact 14-3-3 Binding Site

  1999cited by this paper
• Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25.

  1999influential reference
• Nuclear export of cyclin B1 and its possible role in the DNA damage‐induced G2 checkpoint

  1998influential reference
• 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts.

  1998cited by this paper
• The Xenopus Chk1 Protein Kinase Mediates a Caffeine-sensitive Pathway of Checkpoint Control in Cell-free Extracts

  1998cited by this paper
• Polo-like kinases: positive regulators of cell division from start to finish.

  1998cited by this paper
• MPF localization is controlled by nuclear export

  1998cited by this paper
• Polo-like kinases: a team that plays throughout mitosis.

  1998cited by this paper
• Proteins Act as Negative Regulators of the Mitotic Inducer Cdc 25 in Xenopus Egg Extracts

  1998cited by this paper
• Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1.

  1998influential reference
• Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

  1998cited by this paper
• C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.

  1998cited by this paper
• Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

  1997influential reference
• Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase.

  1997cited by this paper
• A DNA Damage Checkpoint Meets the Cell Cycle Engine

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation.

  1997cited by this paper
• Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts

  1996cited by this paper
• Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein

  1996cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Cdc2 regulatory factors.

  1994cited by this paper
• Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis.

  1994cited by this paper
• Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase.

  1993influential reference
• Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.

  1993influential reference
• Phosphorylation and activation of human cdc25‐C by cdc2‐‐cyclin B and its involvement in the self‐amplification of MPF at mitosis.

  1993influential reference
• Chromosome condensation caused by loss of RCC1 function requires the cdc25C protein that is located in the cytoplasm.

  1992influential reference
• Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

  1992cited by this paper
• Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.

  1992cited by this paper
• Cyclins and their partners: from a simple idea to complicated reality.

  1991cited by this paper
• Universal control mechanism regulating onset of M-phase

  1990cited by this paper

• The cAMP-PKA signaling initiates mitosis by phosphorylating Bora

  2025cites this paper
• Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery

  2025cites this paper
• AURKA inhibition amplifies DNA replication stress to foster WEE1 kinase dependency and synergistic antitumor effects with WEE1 inhibition in cancers

  2025cites this paper
• Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer Through Dual Targeting of Cancer Cells and Cancer Stem Cells: Evidence from In Vitro and In Vivo Models

  2025cites this paper
• Extra-Ribosomal Roles for Ribosomal Proteins and Their Relevance to Tumour Suppression, Carcinogenesis and Cancer Progression

  2025cites this paper
• Kinesin KIF16B Participates in G2/M Transition and Microtubule Dynamics via Aurora A‐PLK1 in Oocyte Meiosis

  2025cites this paper
• Transcriptional patterns of cancer-related genes in primary and metastatic tumours revealed by machine learning

  2025cites this paper
• Targeting cell cycle checkpoints for glioma therapy.

  2025cites this paper
• PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition

  2024cites this paper
• Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein.

  2024cites this paper
• Polo-like Kinase 1 Expression as a Biomarker in Colorectal Cancer: A Retrospective Two-Center Study

  2024cites this paper
• 14-3-3ε inhibits premature centriole disengagement by inhibiting the activity of Plk1 and separase

  2024cites this paper
• Serving up health: How phytochemicals transform food into medicine in the battle against cancer

  2024cites this paper
• The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation

  2024cites this paper
• KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway

  2024cites this paper
• Mitotic kinases are emerging therapeutic targets against metastatic breast cancer

  2024cites this paper
• Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies

  2023cites this paper
• CDC6 as a Key Inhibitory Regulator of CDK1 Activation Dynamics and the Timing of Mitotic Entry and Progression

  2023cites this paper
• A novel L-shaped ortho-quinone analog as PLK1 inhibitor blocks prostate cancer cells in G2 phase.

  2023cites this paper
• Integrative transcriptomic and proteomics profiling analyses reveals PLK1 as a target of curcumol in hepatocellular carcinoma cells

  2023cites this paper
• Combined Aurora Kinase A and CHK1 Inhibition enhances radiosensitivity of triple-negative breast cancer through induction of apoptosis and mitotic catastrophe associated with excessive DNA damage.

  2023cites this paper
• Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition

  2023cites this paper
• Biodegradable Carbon Dioxide‐Derived Non‐Viral Gene Vectors for Osteosarcoma Gene Therapy

  2022cites this paper
• Present and Future Perspective on PLK1 Inhibition in Cancer Treatment

  2022cites this paper
• Determination of the anti-polo like kinase 1 potential of novel derivatives of thiophene using oncoinformatics approach

  2022cites this paper
• Targeting the Complex Protein Network of MYCN-amplified Anaplastic Ependymoma: A Case Report

  2022cites this paper
• Par-4 in Cell Cycle Regulation

  2022cites this paper
• Polyploid giant cancer cells and cancer progression

  2022cites this paper
• DNA damage checkpoint execution and the rules of its disengagement

  2022cites this paper
• Regulators CDCA8 as potential targets and biomarkers for the prognosis of human skin cutaneous melanoma

  2022cites this paper
• Investigating the Functions of PLK4 in Epigenetic Regulation

  2021cites this paper
• Mitotic waves in an import-diffusion model with multiple nuclei in a shared cytoplasm

  2021cites this paper
• Integrative Transcriptome Sequencing Reveals the Molecular Difference of Maturation Process of Ovary and Testis in Mud Crab Scylla paramamosain

  2021cites this paper
• Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape

  2021cites this paper
• Polo-like kinase 1 (PLK1) signaling in cancer and beyond.

  2021cites this paper
• TCTP protein degradation by targeting mTORC1 and signaling through S6K, Akt, and Plk1 sensitizes lung cancer cells to DNA-damaging drugs

  2021cites this paper
• CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension

  2021influential citation
• Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer

  2021cites this paper
• Centriole is the pivot co‐ordinating dynamic signaling for cell proliferation and organization during early development in the vertebrates

  2021cites this paper
• The CINs of Polo-Like Kinase 1 in Cancer

  2020cites this paper
• Molecular characterisation of putative WNT signalling protein, Leucine zipper and ICAT domain containing (LZIC)

  2020cites this paper
• Novel molecular targets in hepatocellular carcinoma

  2020cites this paper
• The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

  2020cites this paper
• Dynamic bistable switches enhance robustness and accuracy of cell cycle transitions

  2020cites this paper
• BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells

  2020cites this paper
• The Molecular Interactome of the Centriole, Cell Cycle and Ciliary Proteins Modulates Cell Mass Growth and Structural Organization During Development in Metazoans

  2020cites this paper
• Centrosome Amplification and Tumorigenesis: Cause or Effect?

  2019cites this paper
• MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate

  2019cites this paper
• Phosphatases in Mitosis: Roles and Regulation

  2019cites this paper
• Molecular Mechanisms of Prophase I Meiotic Arrest Maintenance and Meiotic Resumption in Mammalian Oocytes

  2019cites this paper
• Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck

  2019influential citation
• Inhibition of polo-like kinase 1 suppresses microtubule dynamics in MCF-7 cells

  2019cites this paper
• Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.

  2019cites this paper
• Triggering mitosis

  2019cites this paper
• Transcriptional regulation of G2/M regulatory proteins and perturbation of G2/M Cell cycle transition by a traditional Chinese medicine recipe.

  2019cites this paper
• Dissecting the mechanisms of cell division

  2019cites this paper
• Signal Transduction in Diffuse Intrinsic Pontine Glioma

  2019cites this paper
• Novel Chiral Chalcone Analogs that Induce M Phase Arrest and Apoptosis in HeLa Cells

  2019cites this paper
• Boolean model of growth signaling, cell cycle and apoptosis predicts the molecular mechanism of aberrant cell cycle progression driven by hyperactive PI3K

  2019cites this paper
• Wee1 Rather Than Plk1 Is Inhibited by AZD1775 at Therapeutically Relevant Concentrations

  2019cites this paper
• Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCC.

  2018cites this paper
• Rôle de la GTPase ARF6 dans la prolifération cellulaire

  2018cites this paper
• Cell cycle and complement inhibitors may be specific for treatment of spinal cord injury in aged and young mice: transcriptomic analyses

  2018cites this paper
• 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase

  2018cites this paper
• Lamprey Prohibitin2 Arrest G2/M Phase Transition of HeLa Cells through Down-regulating Expression and Phosphorylation Level of Cell Cycle Proteins

  2018cites this paper
• Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds.

  2018cites this paper
• Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice

  2018cites this paper
• MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma.

  2018cites this paper
• A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key

  2018cites this paper
• PIN1 in Cell Cycle Control and Cancer

  2018cites this paper
• Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells

  2018cites this paper
• Effect of PLK1 inhibition on cisplatin‐resistant gastric cancer cells

  2018cites this paper
• LFM-A13, a potent inhibitor of polo-like kinase, inhibits breast carcinogenesis by suppressing proliferation activity and inducing apoptosis in breast tumors of mice

  2018cites this paper
• Cell cycle regulation in adrenocortical carcinoma

  2018cites this paper
• THE ROLE OF PLK 4 IN DNA DAMAGE PATHWAYS AND ENTRY INTO MITOSIS by Sepal

  2018cites this paper
• The Meisenheimer Complex as a Paradigm in Drug Discovery: Reversible Covalent Inhibition through C67 of the ATP Binding Site of PLK1.

  2018cites this paper
• Cervical Cancer Growth Is Regulated by a c-ABL-PLK1 Signaling Axis.

  2017cites this paper
• Characterisation of the phosphatase control system that prevents premature mitotic entry in mammalian cells

  2017cites this paper
• Exploiting Genetic Vulnerabilities to Overcome Treatment Resistance in Adult Gliomas

  2017cites this paper
• Coupling of Polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry

  2017cites this paper
• Regulation of Cell Division.

  2017cites this paper
• Cell Proliferation and Differentiation

  2017cites this paper
• Regulatory functional territory of PLK-1 and their substrates beyond mitosis

  2017cites this paper
• Contribution de l’activité des domaines polo-box et kinase de la Polo-like kinase Cdc5 dans ses fonctions de régulation mitotique et dans le maintien de la stabilité du génome

  2017cites this paper
• Bistability of mitotic entry and exit switches during open mitosis in mammalian cells

  2016cites this paper
• Helicobacter pylori attenuates proliferation of RAW264.7 monocytic macrophage cells by downregulating cell cycle genes / Grace Tan Min Yi

  2016cites this paper
• Novel Strategies in the Treatment of COPD

  2016cites this paper
• UV Irradiation Triggers Cylindromatosis Translocation, Modification, and Degradation in a Proteasome-Independent Manner

  2016cites this paper
• Modulation of Mammalian Cell Behavior for Enhancing Polymer-mediated Transgene Expression

  2016cites this paper
• Inhibitors of the Polo‐Box Domain of Polo‐Like Kinase 1

  2016cites this paper
• Polo-Like Kinase 1 and Smooth Muscle Cells in Coronary Artery Bypass Conduits and Coronary Arteries Following Angioplasty

  2016cites this paper
• Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies

  2016cites this paper
• Deregulation of vital mitotic kinase–phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia

  2016influential citation
• In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach.

  2016cites this paper
• Maintaining Genome Stability in Defiance of Mitotic DNA Damage

  2016cites this paper
• Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis

  2016cites this paper
• Kinomics Screening Identifies Aberrant Phosphorylation of CDC25C in FLT3-ITD-positive AML.

  2016cites this paper
• Multiple Requirements of PLK1 during Mouse Oocyte Maturation

  2015cites this paper
• PLK4 Is Essential for Meiotic Resumption in Mouse Oocytes1

  2015cites this paper
• Scaffolding during the cell cycle by A-kinase anchoring proteins

  2015cites this paper